medical news

Geneos Therapeutics’ Groundbreaking Cancer Vaccine Trial Yields Remarkable Results: Complete Response Achieved in 8 out of 34 Patients with Advanced Liver Cancer

PLYMOUTH MEETING, PA — Geneos Therapeutics, a clinical-stage biotherapeutics company, recenlty announced updated data from GT-30, an ongoing single-arm open-label multi-center Phase 1b/2a study in second-line advanced hepatocellular carcinoma (HCC). …

Geneos Therapeutics’ Groundbreaking Cancer Vaccine Trial Yields Remarkable Results: Complete Response Achieved in 8 out of 34 Patients with Advanced Liver Cancer Read More